Free Trial
LON:BVXP

Bioventix (BVXP) Share Price, News & Analysis

Bioventix logo
GBX 2,692 -8.00 (-0.30%)
As of 05/2/2025 11:46 AM Eastern

About Bioventix Stock (LON:BVXP)

Key Stats

Today's Range
2,600
2,750
50-Day Range
2,370
2,975
52-Week Range
2,200
4,550
Volume
22,728 shs
Average Volume
8,293 shs
Market Capitalization
£140.96 million
P/E Ratio
17.41
Dividend Yield
5.87%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide. The company offers a portfolio of purified SMAs for thyroid, vitamin D, cardiac, drugs of abuse, fertility, oncology, and miscellaneous indications; and Pyrene (HOP-G) ELISA kit to monitor human exposure to industrial pollutants. It also provides contract SMAs and recombinant services. Bioventix PLC was incorporated in 2003 and is based in Farnham, United Kingdom.

Receive BVXP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Bioventix and its competitors with MarketBeat's FREE daily newsletter.

BVXP Stock News Headlines

Trump wipes out trillions overnight…
Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out nearly $5 trillion in wealth from the S&P 500 and $6.4 trillion from the Dow Jones… Not to mention the countless trillions of dollars lost in every market around the world… leaving the major political powers scrambling in fear of Trump’s next move.
3 UK Dividend Stocks Offering Yields Up To 7.2%
3 top AIM stocks to consider buying before they recover
See More Headlines

BVXP Stock Analysis - Frequently Asked Questions

Bioventix's stock was trading at GBX 3,240 on January 1st, 2025. Since then, BVXP shares have decreased by 16.9% and is now trading at GBX 2,692.
View the best growth stocks for 2025 here
.

Bioventix PLC (LON:BVXP) announced its quarterly earnings results on Monday, March, 31st. The biotechnology company reported $72.27 earnings per share for the quarter. Bioventix had a net margin of 59.51% and a trailing twelve-month return on equity of 69.09%.

Shares of BVXP stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Based on aggregate information from My MarketBeat watchlists, some other companies that Bioventix investors own include Lancashire (LRE), Avast (AVST), Victrex (VCT), boohoo group (BOO), Tullow Oil (TLW), Airbnb (ABNB) and Avon Protection (AVON).

Company Calendar

Last Earnings
3/31/2025
Record date for 4/25 Dividend
4/10/2025
Ex-Dividend for 4/25 Dividend
4/10/2025
Dividend Payable
4/25/2025
Today
5/04/2025

Industry, Sector and Symbol

Stock Exchange
LON
Sector
Medical
Industry
Biotechnology
Sub-Industry
Cannabis
Current Symbol
LON:BVXP
CIK
N/A
Fax
N/A
Employees
12
Year Founded
N/A

Profitability

Trailing P/E Ratio
17.41
Forward P/E Ratio
16.19
P/E Growth
N/A
Net Income
£8.12 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
£13.65 million
Cash Flow
GBX 87.15 per share
Price / Cash Flow
30.89
Book Value
GBX 229.94 per share
Price / Book
11.71

Miscellaneous

Free Float
N/A
Market Cap
£140.96 million
Optionable
Not Optionable
Beta
0.35
The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

This page (LON:BVXP) was last updated on 5/4/2025 by MarketBeat.com Staff
From Our Partners